The team got to work planning a solution that was to be fast, efficient and portable: an on-demand service available in every mobile phone with a camera. AI could be used to cross-reference any package, pill or powder with existing production print files, as well as trace sources and routes of counterfeits and compare them to similar items that had surfaced somewhere previously.
“Our mission, from the very beginning, has been to protect people and societies from these counterfeit products,” says Kannas.
In October 2019, TrueMed Oy – the company – was officially founded. That same month, a pilot with a TOP5 global pharmaceutical company kicked off – with other pilots following in its wake.
“In addition to Big Pharma, we have work ongoing with public safety and public health players,” Kannas says, citing also good connections with World Health Organization (WHO) and UNAIDS.
Easy-to-use health tech
From day one, the app and the system was designed to be easy to use at all levels of expertise.
“As a consequence, hospitals, medical providers, law enforcement professionals and one day even consumers can all identify harmful products with TrueMed,” Kannas says.
As the coronavirus crisis hit, TrueMed became engaged in medical product recognition; helping to make sure that, for example, face masks and coronavirus test kits were legit.
“Next up in the pipeline, we will focus on vaccine protection.”
Looking forward, Kannas believes that the company will continue to benefit from the vibrant health tech scene in Helsinki.
“The local ecosystem has a good momentum going,” he says.
In addition, Kannas perceives Health Capital Helsinki to be a key part of the current upward trend.
“Health Capital Helsinki is really a solid platform for the entire industry.”